Last reviewed · How we verify

morphine IV PCA

Talphera, Inc · Phase 3 active Small molecule

Morphine binds to opioid receptors in the brain and spinal cord, producing analgesia and altering mood.

Morphine binds to opioid receptors in the brain and spinal cord, producing analgesia and altering mood. Used for Severe pain, Cancer pain.

At a glance

Generic namemorphine IV PCA
SponsorTalphera, Inc
Drug classopioid
Targetmu-opioid receptor
ModalitySmall molecule
Therapeutic areaPain management
PhasePhase 3

Mechanism of action

Morphine is a mu-opioid receptor agonist, which means it activates these receptors to produce its effects. This activation leads to the inhibition of pain transmission in the spinal cord and the release of neurotransmitters that produce feelings of euphoria and relaxation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results